GlassScriptPhysician profile
John W Desalvo
NPI 1497745350
$401.57
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $29.17 · 2021: $213 · 2022: $29.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $152.73 | 2019-2022 | |
| Daiichi Sankyo INC. | $58.01 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $29.62 | 2019 | |
| Abbvie INC. | $28.04 | 2021 | |
| Coopersurgical, INC. | $26.39 | 2019 | |
| Organon LLC | $21.34 | 2021 | |
| Allergan, INC. | $19.92 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.53 | 2021 | |
| Boston Scientific Corporation | $14.28 | 2022 | |
| Avion Pharmaceuticals | $13.64 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.54 | 2019 | |
| Aspira Women'S Health INC | $10.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Desalvo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.